Showing results (1121-1130 of 1,598) with videos related to
Sort By:
Pageof 160
Cancer Journal (Sudbury, Mass.)|July 26, 2022
Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell TherapyJohn E Mullinax, Michael E Egger, Martin McCarter, et al.Cancer Journal (Sudbury, Mass.)|July 26, 2022
Current State of Cell Therapies for Genitourinary MalignanciesMohammed A Alkhouli, Sarah Bazargan, Shari Pilon-Thomas, et al.Cancer Journal (Sudbury, Mass.)|July 26, 2022
Current State of Cell Therapies for Gastrointestinal CancersKeshav Kooragayala, Johanna Lou, Young Ki HongCancer Journal (Sudbury, Mass.)|February 4, 2016
Idelalisib: Targeting the PI3 Kinase Pathway in Non-Hodgkin LymphomaPierre Sujobert, Catherine Rioufol, Gilles A SallesCancer Journal (Sudbury, Mass.)|February 4, 2016
Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin LymphomaJose Caetano Villasboas, Stephen AnsellCancer Journal (Sudbury, Mass.)|February 4, 2016
Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative DisordersJorge J Castillo, Steven P Treon, Matthew S DavidsCancer Journal (Sudbury, Mass.)|September 22, 2015
Immunotherapy for Advanced Lung CancerRamsey Asmar, Naiyer A RizviCancer Journal (Sudbury, Mass.)|August 8, 2014
B7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future directionScott Gettinger, Roy S HerbstCancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Therapy in MelanomaMargaret K CallahanCancer Journal (Sudbury, Mass.)|April 26, 2016
The State of Immune Checkpoint Inhibition in Urothelial Carcinoma: Current Evidence and Future Areas of ExplorationMatthew T Campbell, Arlene O Siefker-Radtke, Jianjun GaoPageof 160